DBP
Generated by GPT-5-miniExpansion Funnel Raw 85 → Dedup 0 → NER 0 → Enqueued 0
| DBP | |
|---|---|
| Name | DBP |
| Othernames | dibutyl phthalate; 1,2-benzenedicarboxylic acid, dibutyl ester |
| Formula | C16H22O4 |
| Molar mass | 278.34 g·mol−1 |
| Appearance | colorless oily liquid |
| Density | 1.045 g·cm−3 |
| Mp | −35 °C |
| Bp | 340 °C (decomposes) |
| Solubility | low in water |
DBP DBP is an industrial chemical primarily known as dibutyl phthalate, a phthalate ester used historically as a plasticizer. It has been applied across manufacturing sectors involving Bayer, Dow Chemical Company, BASF, DuPont, ExxonMobil supply chains and appears in legacy products from Johnson & Johnson, Procter & Gamble, 3M, Honeywell International. DBP intersects with public policy debates involving U.S. Environmental Protection Agency, European Chemicals Agency, World Health Organization, United Nations Environment Programme and features in litigation and regulatory actions connected to Consumer Product Safety Commission and European Commission directives.
Definition and Nomenclature
Dibutyl phthalate is systematically named 1,2-benzenedicarboxylic acid, dibutyl ester and is abbreviated in industry literature as DBP. Chemical identifiers used by American Chemical Society, Chemical Abstracts Service and International Union of Pure and Applied Chemistry facilitate cross-referencing in inventories such as those maintained by REACH and the Toxic Substances Control Act database. Trade names and synonyms were common in catalogs from Shell Oil Company and specialty chemical firms like Eastman Chemical Company.
Biological and Medical Contexts
DBP has been examined in studies conducted at institutions including Harvard University, Johns Hopkins University School of Medicine, National Institutes of Health, Karolinska Institutet and University of California, Berkeley. Research links DBP exposure to endocrine-related outcomes studied in cohorts like those assembled by Framingham Heart Study and Nurses' Health Study. Clinical toxicology case reports from Mayo Clinic and Cleveland Clinic documented acute exposures, while developmental studies referenced protocols from National Institute of Child Health and Human Development and World Health Organization laboratories. DBP appears in biomonitoring surveys by Centers for Disease Control and Prevention and reproductive research published in journals affiliated with The Lancet and Nature Medicine.
Chemical and Environmental Aspects
As a phthalate ester, DBP is chemically related to compounds produced by I.G. Farben-era chemistry and later commercialized by firms such as Monsanto. Environmental fate studies have involved sampling in regions affected by petrochemical activity near facilities like Port Arthur, Texas, Rheinland basin, and Pearl River Delta. DBP’s environmental behavior—sorption, degradation, volatilization—has been characterized in work by Environmental Protection Agency laboratories, European Chemicals Agency reports, and academic groups at ETH Zurich and Imperial College London. DBP is detected in media including indoor air measured by teams from National Institute for Occupational Safety and Health and in sediments analyzed by researchers at Scripps Institution of Oceanography.
Measurement and Analytical Methods
Analytical determination of DBP relies on methods standardized by ISO, ASTM International, U.S. EPA Method 8270D, and protocols in textbooks from Wiley-published analytical chemistry authors. Techniques include gas chromatography–mass spectrometry used in laboratories at Agilent Technologies and Thermo Fisher Scientific, high-performance liquid chromatography workflows adopted by Shimadzu Corporation, and tandem mass spectrometry applied in clinical labs affiliated with Mayo Clinic. Sample preparation approaches—solid-phase extraction, liquid-liquid extraction, thermal desorption—are described in method manuals from Society of Environmental Toxicology and Chemistry and interlaboratory studies coordinated by OECD.
Health Effects and Toxicology
Toxicological profiles for DBP have been compiled by U.S. EPA, European Chemicals Agency, Agency for Toxic Substances and Disease Registry, and researchers at National Toxicology Program. Animal studies at institutions such as Riken and Charles River Laboratories showed effects on reproductive tract development and endocrine signaling, prompting reviews in journals from Elsevier and Springer Nature. Human epidemiological analyses by teams at Stanford University and Columbia University explored associations between prenatal DBP biomarkers and neurodevelopmental outcomes tracked in birth cohorts including Generation R Study and Avon Longitudinal Study of Parents and Children. Mechanistic work involves nuclear receptor pathways characterized in labs linked to Max Planck Society.
Regulatory Standards and Guidelines
Regulatory actions addressing DBP have been enacted by European Commission under REACH restrictions, listed in annexes of the Restriction of Hazardous Substances Directive, and targeted by the U.S. Consumer Product Safety Improvement Act. International guidance from World Health Organization and assessments by Organisation for Economic Co-operation and Development have influenced limits adopted by national agencies such as Health Canada, Australian Department of Health, and Japan Ministry of Health, Labour and Welfare. Industry responses include reformulation initiatives by Unilever, L'Oréal, and packaging changes promoted by International Organization for Standardization committees.
Research and Emerging Issues
Current research agendas involve exposure reduction strategies advanced by Greenpeace and Environmental Working Group, alternative plasticizer development by companies like Evonik Industries and academic consortia at MIT and University of Cambridge, and long-term monitoring projects coordinated through networks such as Global Monitoring Laboratory (NOAA) and International POPs Elimination Network. Emerging concerns address mixture toxicology explored in collaborative grants from National Institutes of Health, climate-driven distribution shifts studied by United Nations Environment Programme, and legal precedents set in litigation involving European Court of Justice and U.S. District Courts.